Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiome and Serum Metabolome Alterations in Attention-deficit/Hyperactivity Disorder Patients

NCT03447223 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT03447223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03447223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiome and Serum Metabolome Alterations in Attention-deficit/Hyperactivity Disorder Patients
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Completed
Start date
March 20, 2018
Completion date
May 27, 2020
Enrollment
207 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder